Hint mode is switched on Switch off
For swift navigation between sections

Domestic bonds: Sanofi, 1.875% 21mar2038, EUR
FR0013324373

Download
Copy issue information to clipboard
Copy issue information to clipboard
✓
Copy

Issue
Issuer
  • M
    -
    ****
  • S&P
    -
    ****
  • F
    -
    -*
*in local currency
Status
Outstanding
Amount
1,250,000,000 EUR
Placement
***
Early redemption
*** (-)
Country of risk
France
Current coupon
***%
Price
***%
Yield / Duration
-
Calculator What is a calculator?
Corporate Actions Issuer news
Add issue to Watchlist
Choose all Reset all
{{ watchlistErrorMsg }}
Save Collapse
Adding issue to the Watchlist is not possible because there are no quotes from exchanges for it.
Calculator
What is a calculator?
Register
to order full access
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
from
to
ADD-IN
Cbonds add-in API
bond data api
More than 2,500 records have been found, please specify your request
* Data is not available within the selected subscription
Latest data on
Quotes from market participants are indicative

Stock exchange and OTC quotes

Request additional prices

Issue information

Profile
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, ...
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. Sanofi has a portfolio of prescription drugs, vaccines, generics and consumer healthcare products. In December 2011, Sanofi announced that it completed the divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International, Inc. The Company is active domestically and abroad, including other European countries, North and Latin Americas, Asia, Africa and Middle East. As of January 31, 2012, the Company’s major shareholder was L’oreal with a stake of 8.82%.
Show more Hide
  • Issuer
    Go to the issuer page
    Sanofi
  • Full issuer name
    Sanofi SA
  • Sector
    corporate
  • Industry
    Healthсare
Volume
  • Amount
    1,250,000,000 EUR
  • Outstanding face value amount
    1,250,000,000 EUR
  • USD equivalent
    1,518,950,000 USD
Nominal
  • Nominal
    100,000 EUR
  • Outstanding face value
    *** EUR
  • Par amount, integral multiple
    *** EUR

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Delay days
    *** days
  • Maturity date
    ***
  • Early redemption date
    ***

Cash flow

Early redemption terms

***

Register
to order full access
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Placement

  • Placement method
    Open subscription
  • Order book
    *** (***) - *** (***)
  • Coupon (Yield) Guidance
    ***% - ***% (*** - ***%)
  • Issuer rating on issue date (M/S&P/F)
    *** / *** / ***
  • Placement
    *** - ***
  • Initial issue price (yield)
    (***%)
  • Bids
    *** EUR
  • Number of bids
    ***
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Listing
    ***
Participants
  • Bookrunner
    ***, ***, ***, ***, ***, ***, ***, ***, ***, ***
  • Depository
    ***
  • Arranger Legal Adviser (International law)
    ***

Conversion and exchange

  • Convertion date
    ***
  • Initial premium
    ***%
  • Convertible until
    ***
  • Lock-up
    *** days
  • Conversion terms
    ***

Additional information

***

Latest issues

Show all

News

04/06/2020 Fitch Ratings affirms Sanofi at "A+" (LT Int. Scale (foreign curr.) credit rating); outlook stable
04/06/2020 S&P Global Ratings revised outlook on Sanofi to stable and affirmed at "AA" (Foreign Currency LT) credit rating
04/06/2020 S&P Global Ratings revised outlook on Sanofi to stable and affirmed at "AA" (Local Currency LT) credit rating
03/06/2020 Moody's Investors Service affirms Sanofi at "A1" (LT- local currency credit rating); outlook stable
03/06/2020 Moody's Investors Service affirms Sanofi at "A1" (LT- foreign currency credit rating); outlook stable
20/06/2019 Fitch Ratings downgrades LT Int. Scale (foreign curr.) credit rating of Sanofi to "A+"; outlook stable
30/04/2019 S&P Global Ratings assigns "AA" (Local Currency LT credit rating) to Sanofi; outlook negative
30/04/2019 S&P Global Ratings assigns "AA" (Foreign Currency LT credit rating) to Sanofi; outlook negative
27/06/2018 Fitch Ratings affirms Sanofi at "AA-" (LT Int. Scale (foreign curr.) credit rating); outlook negative
13/06/2018 New bond issue: Sanofi issued international bonds (US801060AD60) with a 3.625% coupon for USD 1,000.0m maturing in 2028
All organization news

Stocks

Identifiers

  • Registration
    ***
  • Date of program registration
    ***
  • ISIN RegS
    FR0013324373
  • CUSIP RegS
    ***
  • CUSIP 144A
    ***
  • CFI RegS
    DTFUFB
  • FIGI RegS
    BBG00K9ZVVS5
  • WKN RegS
    A19X5N
  • Ticker
    SANFP 1.875 03/21/38 20FX
  • Type of security by CBR
    ***

Ratings



Bond classification

  • Coupon bonds
  • Bearer
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Floating rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Indexed
  • Supranational bond issues
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Subordinated
  • Sukuk
  • Trace-eligible
Show more Hide

Restructuring

***

***

IFRS/US GAAP reports

2020
II q eng
2019
II q eng
IV q eng
2018
II q eng
IV q eng
2017
IV q eng
Show all Hide

Holders

Copyright (c) 2004-2021 CbondS